SOPHARMA (SPH): Sales revenues for March 2021 - raport 13
Raport ESPI
UNI - EN REPORT No
13
/
2021
UNI - EN REPORT No13/2021
Sofia, Bulgaria, April 5, 2021 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (SFA: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for March 2021 the Company recorded a decrease in sales of 56% compared to the same month of 2020, incl. 55% decrease in domestic sales and 12% decrease in export sales.
